{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:31:42Z","timestamp":1762176702794},"reference-count":28,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A major challenge in the management of primary hyperparathyroidism (pHPT) is the decision regarding which patients should undergo parathyroidectomy (PTX), although the Consensus Development Conference of the NIH has proposed guidelines for the indication of surgery. In the present study, changes in bone mineral density (BMD) after PTX were compared between pHPT patients who did and did not meet the NIH criteria, and we further tried to predict the BMD change after PTX from preoperative parameters. The subjects were 44 pHPT patients (30 women and 14 men) who had had successful PTX. Lumbar and radial BMD were measured before and 1 yr after PTX by dual energy x-ray absorptiometry and single photon absorptiometry, respectively. Average annual percent increases in lumbar and radial BMD after PTX were 12.2 \u00b1 1.4% and 11.6 \u00b1 1.6% (mean \u00b1 sem), respectively, and those net increases were 0.0803 \u00b1 0.0008 and 0.0484 \u00b1 0.0006 g\/cm2, respectively. There were no significant differences in percent or net changes in either radial or lumbar BMD after PTX between the groups divided according to each of the NIH criteria, such as age (\u226550 and &amp;lt;50 yr), serum calcium level (\u226512 and&amp;lt;12 mg\/dL) or the existence of urinary stones (presence and absence). On the other hand, when the subjects were divided on the basis of radial BMD (above and below a z-score of \u22122), the annual percent and net increases in lumbar BMD and percent increase in radial BMD after PTX were significantly higher in the group with the lower z-score. Next, patients were divided into two groups with and without the indication of PTX based on NIH guidelines. Twenty-nine patients had the surgical indication by meeting one or more of these criteria and 15 patients had no indication without meeting any of the criteria. There were no significant differences between the two groups in annual percent or net changes in radial or lumbar BMD after PTX. A stepwise multiple regression analysis revealed that serum alkaline phosphatase level and the severity of cortical bone mass reduction were the best predictors of both percentage and net changes in lumbar BMD, with high determination coefficients (r2 &amp;gt; 0.7). In conclusion, a considerable increase in BMD could be obtained after PTX even in patients without surgical indication from the NIH. Alkaline phosphatase and the severity of cortical bone mass reduction are clinically useful for predicting the changes in lumbar BMD after PTX. The present findings provide a useful clue for the indication of surgery in pHPT.<\/jats:p>","DOI":"10.1210\/jcem.85.5.6604","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:05:47Z","timestamp":1389200747000},"page":"1901-1907","source":"Crossref","is-referenced-by-count":4,"title":["Prediction of Bone Mass Change after Parathyroidectomy in Patients with Primary Hyperparathyroidism*"],"prefix":"10.1210","volume":"85","author":[{"given":"Daiki","family":"Nakaoka","sequence":"first","affiliation":[{"name":"Third Division, Department of Medicine, Kobe University School of Medicine (D.N., T.S., T.K., T.Y., K.C.), Kobe 650-0017"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Third Division, Department of Medicine, Kobe University School of Medicine (D.N., T.S., T.K., T.Y., K.C.), Kobe 650-0017"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Third Division, Department of Medicine, Kobe University School of Medicine (D.N., T.S., T.K., T.Y., K.C.), Kobe 650-0017"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Third Division, Department of Medicine, Kobe University School of Medicine (D.N., T.S., T.K., T.Y., K.C.), Kobe 650-0017"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Kuma Hospital (A.K.), Kobe 650-0011, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Chihara","sequence":"additional","affiliation":[{"name":"Third Division, Department of Medicine, Kobe University School of Medicine (D.N., T.S., T.K., T.Y., K.C.), Kobe 650-0017"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613450512400_R1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","article-title":"Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement.","volume":"114","year":"1991","journal-title":"Ann Intern Med"},{"key":"2020071613450512400_R2","first-page":"2036","article-title":"Evaluation and management of primary hyperparathyroidism.","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613450512400_R3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(80)91783-3","article-title":"Primary hyperparathyroidism: changes in the pattern of clinical presentation.","volume":"1","author":"Mundy","year":"1980","journal-title":"Lancet"},{"key":"2020071613450512400_R4","first-page":"729","article-title":"Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism.","volume":"80","author":"Silverberg","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613450512400_R5","first-page":"723","article-title":"Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism.","volume":"80","author":"Silverberg","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613450512400_R6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2796.1998.00241.x","article-title":"Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.","volume":"243","author":"Vandemarsson","year":"1998","journal-title":"J Intern Med"},{"key":"2020071613450512400_R7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0039-6060(97)90328-7","article-title":"Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.","volume":"122","author":"Thorsen","year":"1997","journal-title":"Surgery"},{"key":"2020071613450512400_R8","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"2020071613450512400_R9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/000456329002700114","article-title":"Immunoradiometric assay for intact human parathyroid hormone: characteristics, clinical application and comparison with a radio-immunoassay.","volume":"27","author":"Frolich","year":"1990","journal-title":"Ann Clin Biochem"},{"key":"2020071613450512400_R10","first-page":"807","article-title":"Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic states.","volume":"65","author":"Fukase","year":"1989","journal-title":"Nippon Naibunpi Gakkai Zasshi"},{"key":"2020071613450512400_R11","first-page":"525","article-title":"The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.","volume":"74","author":"D\u2019Amour","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613450512400_R12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1172\/JCI108077","article-title":"Metabolism of immunoreactive parathyroid hormone in the dog.","volume":"56","author":"Hruska","year":"1975","journal-title":"J Clin Invest"},{"key":"2020071613450512400_R13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archinte.1990.00390190133021","article-title":"Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism.","volume":"150","author":"Martin","year":"1990","journal-title":"Arch Intern Med"},{"key":"2020071613450512400_R14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00004424-198211000-00013","article-title":"Sequential changes in bone density before and after parathyroidectomy in primary hyperparathyroidism.","volume":"17","author":"Leppla","year":"1982","journal-title":"Invest Radiol"},{"key":"2020071613450512400_R15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1530\/acta.0.1110494","article-title":"Cortical bone mineral content in primary hyperparathyroidism. Changes after parathyroidectomy.","volume":"111","author":"Mautalen","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2020071613450512400_R16","first-page":"301","article-title":"Trabecular and cortical bone in the radii of women with parathyroid adenoma: a greater trabecular deficit, with a preliminary assessment of recovery after parathyroidectomy.","volume":"2","author":"Hesp","year":"1987","journal-title":"Bone Miner"},{"key":"2020071613450512400_R17","first-page":"206","article-title":"The management of primary hyperparathyroidism.","volume":"31","year":"1983","journal-title":"Henry Ford Hosp Med J"},{"key":"2020071613450512400_R18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/8756-3282(86)90020-7","article-title":"Trabecular bone remodeling and balance in primary hyperparathyroidism.","volume":"7","author":"Eriksen","year":"1986","journal-title":"Bone"},{"key":"2020071613450512400_R19","first-page":"147","article-title":"Bone morphology in primary hyperparathyroidism\u2013a qualitative and quantitative study of 391 cases.","volume":"5","year":"1987","journal-title":"Appl Pathol"},{"key":"2020071613450512400_R20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure.","volume":"70","author":"Parisien","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613450512400_R21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/8756-3282(92)90360-9","article-title":"Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods.","volume":"13","author":"Christiansen","year":"1992","journal-title":"Bone"},{"key":"2020071613450512400_R22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism.","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2020071613450512400_R23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/bmj.280.6228.1340","article-title":"Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.","volume":"280","author":"Reeve","year":"1980","journal-title":"Br Med J"},{"key":"2020071613450512400_R24","first-page":"243","volume":"12","author":"Slovik","year":"1980"},{"key":"2020071613450512400_R25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jcem-67-6-1237","article-title":"The metatarsal cytochemical bioassay of parathyroid hormone: validation, specificity, and application to the study of pseudohypoparathyroidism type I.","volume":"67","author":"Bradbeer","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613450512400_R26","first-page":"4007","article-title":"Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism.","volume":"81","author":"Silverberg","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613450512400_R27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1507\/endocrj.44.595","article-title":"Clinical and biochemical presentation of primary hyperparathyroidism in Kansai district of Japan.","volume":"44","author":"Kobayashi","year":"1997","journal-title":"Endocr J"},{"key":"2020071613450512400_R28","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1359\/jbmr.1997.12.5.856","article-title":"Primary hyperparathyroidism: still evolving?","volume":"12","author":"Silverberg","year":"1997","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/5\/1901\/9059484\/jcem1901.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/5\/1901\/9059484\/jcem1901.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:33:41Z","timestamp":1594946021000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/5\/1901\/2660517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5,1]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.5.6604","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5,1]]}}}